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Type V collagen is mainly found as the α1(V)2α2(V) heterotrimer
which assembles with type I collagen into heterotypic type I/V
collagen fibrils. The α1 chain is coded by COL5A1 and the α2 chain is
coded by COL5A2. The type V collagen helix is buried within the type I
collagen fibril and its N-propeptide projects through the gap zone of




Case 1: causal defect in COL5A1
Patient with nonsense mutation in COL5A1 (c.3769C>T; p.(Arg1257*))
displaying atrophic scarring (A,B) and sequelae of ecchymoses (A).
Furthermore, he displayed typical hallmarks of cEDS with joint
hypermobility and skin hyperextensibility.
Case 2: no causal defect found
Family (B is the proband, A is the daughter of B) with clinical
suspicion of cEDS in whom no defect in COL5A1/COL5A2 could be
identified. Affected family members present with atrophic scarring,
easy bruising, molluscoid pseudotumors, joint hypermobility and
skin hyperextensibility. Single gene sequencing of COL5A1 and
COL5A2 failed to identify a causal defect. Whole exome sequencing
is ongoing.
Case 3: fading boundaries
Whole exome sequencing revealed a de novo splice site defect in
COL5A2, c.2031+1G>T in a boy with a clinical suspicion of Ehlers-
Danlos syndrome, dermatosparaxis type (dEDS). He was a floppy
infant with a club foot and an umbilical hernia. Height and weight
always remained <p10. He suffers from joint dislocations due to
generalized joint hypermobility. His skin is hyperextensible and
fragile with easy bruising. There are multiple widened atrophic
scars, molluscoid pseudotumors and sequelae of ecchymoses.
Facial features are reminiscent of dEDS with swollen eyelids at birth
and epicanthic folds. Pictures at the age of 4 months (A), 2 (B) and
10 (C,D,E,F) years.
Introduction
Type V collagen is a minor fibrillar collagen with a broad tissue distribution. Reduced availability of type V collagen
seems the major disease-causing mechanism of the classical subtype of Ehlers-Danlos syndrome (cEDS), an autosomal
dominant heritable connective tissue disorder hallmarked by generalized joint hypermobility. Large gaps remain in our
knowledge of this disease with few reports of large groups of patients and lack of in-depth characterization of the
molecular defects. Also, there is still a subset of the patients in whom no molecular defect can be identified. We
gathered and analyzed the data of 242 patients with a clinical suspicion of cEDS.
Clinical features of causal mutations
A degree of skin hyperextensibility, atrophic scarring and joint
hypermobility is present in about 95% of the individuals with a causal
defect. More than 90% of the patients have easy bruising, skin
fragility, soft, doughy skin and complications of joint hypermobility.
The presence of molluscoid pseudotumors and subcutaneous
spheroids are relatively rare and unknown features, but function as
highly diagnostic features when present.Individuals with causal
variants in COL5A2 seem to be affected with a more severe/
complicated disease with a significant higher prevalence of club feet,
hernia’s of the abdominal wall, scoliosis and congenital hip
dislocations.
Conclusion
The majority of the cEDS patients harbour mutations in COL5A1; only 15% of all causal defects are located in COL5A2.
More than 50% of the pathological COL5A1 mutations causes a premature termination codon. All pathological variants
in COL5A2 cause structural defects, mostly glycine substitutions. No premature termination codons have been
identified in COL5A2. In about 5-10% of the patients with a clinical diagnosis of cEDS, no causal defect is found in
COL5A1/COL5A2. Whole exome or whole genome sequencing can function as the next diagnostic step.
More than 95% of the patients with causal defects present with atrophic scarring, hyperextensible skin and joint
hypermobility. Patients harboring defects in COL5A2 seem to have a more severe phenotype. Defects in type V
collagen do not seem te be associated with severe vascular complications. Patients with the specific COL1A1 c.934C>T,
p.(Arg312Cys) mutation on the other hand may present as cEDS but seem to have a propensity to arterial rupture.
































Glycine substitutions 2 (1 VUS) 9 1
In frame indels 6 (1 VUS) 3 2
Premature termination codons 16 38 5
Missense 2 2 (1 VUS) (2 VUS) 2
Splice site unknown outcome 1 1 (1 VUS) 14 (2 VUS) 3
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